0409-9045-17 · Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection · Hospira, Inc., a Pfizer Company
What is the status for 0409-9045-17 · Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection · Hospira, Inc., a Pfizer Company?
For 0409-9045-17, generic name is Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection; manufacturer is Hospira, Inc., a Pfizer Company; status is Current; availability now is Unavailable; fda note is Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay, recorded from its source on 2026-11-02.
"initial_posting_date": "02/20/2018", "package_ndc": "0409-9045-17", "generic_name": "Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection", "contact_info": "844-646-4398", "availability": "Unavailable", "related_info": "Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay"
— api.fda.gov, retrieved 2026-11-02
- Package NDC
- 0409-9045-17 verified
- Generic name
- Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection verified
- Manufacturer
- Hospira, Inc., a Pfizer Company verified
- Status
- Current verified
- Availability now
- Unavailable verified
- FDA note
- Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay verified
- Initial posting date
- 02/20/2018 verified
- Last update date
- 10/29/2026 verified
- Days in shortage
- 3179 our reading
- Reason for shortage
- Other verified
- Dosage form
- Injection verified
- Therapeutic category
- Anesthesia verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "10/29/2026", "therapeutic_category": [ "Anesthesia" ], "dosage_form": "Injection", "presentation": "Bupivacaine Hydrochloride with Epinephrine, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-9045-17)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Other", "status": "Current"
— all from api.fda.gov, retrieved 2026-11-02
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000